97 related articles for article (PubMed ID: 24897071)
1. Vascular pattern in enchondroma and chondrosarcoma: clinical and immunohistologic study.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):600-5. PubMed ID: 24897071
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
3. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
[TBL] [Abstract][Full Text] [Related]
4. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
6. Microvasculature and VEGF expression in cartilaginous tumors.
Ayala G; Liu C; Nicosia R; Horowitz S; Lackman R
Hum Pathol; 2000 Mar; 31(3):341-6. PubMed ID: 10746677
[TBL] [Abstract][Full Text] [Related]
7. In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions.
Delaunay-Lemarie C; Vincourt JB; Marie B; Battaglia-Hsu SF; Etienne S; Sirveaux F; Nguyen Thi PL; Magdalou J; Vignaud JM; Gauchotte G
Virchows Arch; 2015 Sep; 467(3):329-37. PubMed ID: 26100916
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
9. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
10. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
[TBL] [Abstract][Full Text] [Related]
11. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors.
Kouvaras E; Christoni Z; Siasios I; Malizos K; Koukoulis GK; Ioannou M
Biotech Histochem; 2019 May; 94(4):283-289. PubMed ID: 30605014
[TBL] [Abstract][Full Text] [Related]
13. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis in cartilage tumors].
Kalinski T; Roessner A
Pathologe; 2010 Oct; 31 Suppl 2():177-82. PubMed ID: 20661574
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
Grifone TJ; Haupt HM; Podolski V; Brooks JJ
Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
19. Tumor grade-related thallium-201 uptake in chondrosarcomas.
Kaya GC; Demir Y; Ozkal S; Sengoz T; Manisali M; Baran O; Koc M; Tuna B; Ozaksoy D; Havitcioglu H
Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
